Answers are grounded in this paper and cite their sources.
The existing health care systems focus on treating diseases rather than preventing them. Patients are generally not testedunless physiological symptoms are appeared. When they do get tested, the results often take several days and can beinconclusive if the disease is at an early stage. In order to facilitate the diagnostics process and make tests more readilyavailable for patients, the concept of “point of care testing” (POCT) has been brought up and developed in recent years.Field effect transistors (FET) using nanomaterial as a kind of biosensors have shown great characteristics for detectionof a wide range of biomolecules due to their label-free, real time and ultrasensitive properties. In this paper, first of all,the working principles of such devices and recent developments in fabrication methods and surface functionalization arestated, and then some current research trends in field-effect transistor nanobiosensors are highlighted. Eventually keyadvantages and challenges of FET-based nanobiosensors as POCT devices are discussed as well.
No takes yet. Share an insight, caveat, or question.
Majid Molaie (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: